Health
Novavax Inks Vaccine Deals In Japan, India; Analyst Sees 70% Stock Upside – Gooruf
As part of the partnership, Novavax ( NVAX ) will license COVID-19 vaccine technology to Takeda for local production and commercialization in Japan. In exchange, Novavax will receive payments based on the achievement of certain development and commercial mile…
Article summary
As part of the partnership, Novavax ( NVAX ) will license COVID-19 vaccine technology to Takeda for local production and commercialization in Japan. In exchange, Novavax will receive payments based on the achievement of certain development and commercial milestones, as well as a portion of vaccine proceeds….
Continue Reading
